SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare launches ‘Prucalshil’ Orally Disintegrating Strips

21 Dec 2021 Evaluate

Shilpa Medicare has launched PRUCALSHIL (Prucalopride) Orally Disintegrating Strips 1 mg and 2 mg in India, a unique formulation developed for the first time in the World. The company has developed a novel ‘Orally Disintegrating Strip (ODS)’ formulation for Prucalopride and obtained subsequent approval from Drug Control General of India. Prucalopride is used for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients. Orally Disintegrating Strips have an advantage such as greater dissolution due to large surface area, more patient compliance than oral tablets, no risk of choking & better taste masking etc.

Orally Disintegrating Strips technology is emerging in novel drug delivery formulations. The company has acquired expertise with compliance oriented research for development of novel and safer drug delivery such as oral strips keeping in mind patient convenience.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×